Source - RNS
RNS Number : 2124K
HSBC Bank plc
19 September 2016
 

19th September 2016

 

 

 

Teva Pharmaceutical Finance Netherlands II B.V.

 

 Post Stabilisation Notice

 

HSBC (contact: Syndicate desk, telephone: +44 207 992 8066) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

 

Issuer:

Teva Pharmaceutical Finance Netherlands II B.V.

Guarantor (if any):

Teva Pharmaceutical Industries Ltd

Aggregate nominal amount:

€1.75bn                  /   €1.5bn                  / €750m

Description:

0.375% July 2020 / 1.125% Oct 2024   / 1.625% Oct 2028

Offer price:

99.644                   / 99.231                      / 98.899

Stabilising Managers:

Barclays, BAML, BNP Paribas, Credit Suisse, HSBC, Mizuho

 

 

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAGGUUPBUPQGGB